The revelation of the crucial involvement of Raf1 and vascular endothelial growth factor (VEGF) mediated signaling pathways in the molecular pathogenesis of liver cancer provided an interesting theoretic basis for applying sorafenib drugs to liver cancer treatment[16,17]. The gene discussed is RAF1; the disease is liver cancer.